Pricing Log in Create free account

MoonLake Immunotherapeutics (MLTX) vs Verastem, Inc. (VSTM)

MoonLake Immunotherapeutics and Verastem, Inc. are both Biotechnology companies. MoonLake Immunotherapeutics and Verastem, Inc. are of similar size ($873.2M and $835.9M). MoonLake Immunotherapeutics has the higher net margin (0.00% vs −231.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, MoonLake Immunotherapeutics leads on 8 and Verastem, Inc. on 5.

Valuation

Metric MLTX VSTM Biotechnology median
P/E n/m n/m 8.50
P/S n/m 9.89 9.71
P/B 1.65 17.32 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 9.29 9.21
Earnings yield (40.21%) (28.44%) (33.15%)
Free cash flow yield (31.91%) (18.73%) (25.50%)

Profitability

Metric MLTX VSTM Biotechnology median
Gross margin 0.00% 86.35% 65.16%
Operating margin 0.00% (182.57%) 0.00%
Net margin 0.00% (231.59%) 0.00%
Free cash flow margin 0.00% (185.31%) 0.00%
Return on equity (67.08%) (471.16%) (56.36%)
Return on assets (51.00%) (100.65%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric MLTX VSTM Biotechnology median
Revenue growth (TTM) — 472.89% 6.02%
EPS growth (last fiscal year) (86.77%) 17.49% 30.26%
Revenue growth, 5-year CAGR — 12.11% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MLTX VSTM Biotechnology median
Debt to equity 0.23 1.48 0.00
Current ratio 12.56 2.25 4.72
Net debt to EBITDA 1.32 0.76 0.96

Dividend

Metric MLTX VSTM Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric MLTX VSTM Biotechnology median
Market cap 873.19m 835.90m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack